Tpg Gp A, LLC Allogene Therapeutics, Inc. Transaction History
Tpg Gp A, LLC
- $3.27 Billion
- Q1 2025
A detailed history of Tpg Gp A, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Tpg Gp A, LLC holds 18,716,306 shares of ALLO stock, worth $24.1 Million. This represents 0.84% of its overall portfolio holdings.
Number of Shares
18,716,306
Previous 18,716,306
-0.0%
Holding current value
$24.1 Million
Previous $39.9 Million
31.46%
% of portfolio
0.84%
Previous 1.1%
Shares
1 transactions
Others Institutions Holding ALLO
# of Institutions
177Shares Held
165MCall Options Held
202KPut Options Held
76.6K-
Black Rock Inc. New York, NY16.4MShares$21.2 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA12.3MShares$15.8 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR11.1MShares$14.3 Million5.97% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.4MShares$13.5 Million1.06% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il10.2MShares$13.2 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $186M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...